Related Experiment Video
Updated: Jul 18, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
HLA class I epitope discovery in type 1 diabetes
Peter van Endert1, Yousra Hassainya, Vivian Lindo
1INSERM U580, Hôpital Necker, 161 rue de Sèvres, 75015 Paris, France. vanendert@necker.fr
Annals of the New York Academy of Sciences
|November 30, 2006
Summary
Researchers used reverse immunology to discover type 1 diabetes (T1DM) autoantigens. This approach identified proinsulin (PI) epitopes recognized by CD8+ T cells, aiding in T1DM diagnosis and immune intervention strategies.
Area of Science:
- Immunology
- Endocrinology
- Autoimmunity
Background:
- Type 1 diabetes mellitus (T1DM) involves beta cell destruction by T cells.
- CD8+ T cells are crucial in T1DM pathogenesis, targeting antigens like proinsulin (PI).
- Limited knowledge exists on beta cell epitopes recognized by human CD8+ T cells via HLA class I.
Purpose of the Study:
- To identify HLA class I-restricted proinsulin (PI) epitopes using reverse immunology.
- To establish an inventory of naturally processed beta cell epitopes in T1DM.
- To explore new avenues for T1DM diagnosis and immune intervention.
Main Methods:
- Applied reverse immunology approaches to identify PI epitopes.
- Utilized proteasome digestion of PI and epitope prediction algorithms.
- Validated immunogenicity and natural processing in HLA-A2.1-transgenic mice.
Main Results:
- Identified candidate PI epitopes restricted by HLA-A2.1 and other HLA class I molecules.
- Demonstrated immunogenicity and natural processing of identified PI epitopes.
- Confirmed recognition of multiple PI epitopes by CD8+ T cells from T1DM and healthy individuals.
Conclusions:
- Reverse immunology is a powerful strategy for discovering T1DM-related epitopes.
- DNA vaccination in HLA-transgenic mice can map additional T1DM antigen epitopes.
- Characterizing autoreactive CD8+ T cell responses can advance T1DM diagnosis and treatment.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...